Israel, IP, Innovation, Insulin Prices & More with Adam Mossoff | Yaron Brook Interviews
Yaron Brook Show
00:00
Navigating Intellectual Property in Healthcare
This chapter explores the intricate issues surrounding intellectual property (IP) in the healthcare sector, particularly in the context of the Inflation Reduction Act and its impact on drug pricing and innovation. It discusses ongoing legal battles over government price controls and the influence of judicial perspectives on patent regulations. The chapter also dives into the complexities of pharmaceutical pricing, drug development, and the effects of regulatory interventions on accessibility and innovation.
Transcript
Play full episode
